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Introduction 81
Anaerobic gut bacteria play a pivotal role in human health and disease, most of which are 82 strict/obligate anaerobes. Due to the oxygen-sensitivity of these bacteria, it is technically 83 challenging to study their interaction with oxygen-requiring gut epithelial cells in vitro. 84 Although many of the bacteria can survive oxygen by mechanisms such as sporulation; 85 oxygen-free conditions are required for the anaerobic bacteria to grow. 1 Recently, a 86 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 number of different anaerobe-epithelial co-culture systems have been developed. These 87 co-culture systems allow research of both aerobic (i.e. epithelial) cells and specific strains 88 of anaerobic bacteria within one system. Development of representative co-culture 89 systems that can mimic the gastrointestinal ecosystem are valuable tools to study host-90 microbiota interactions in detail at the mechanistic level. This review will first discuss the 91 role of the human gut microbiota in health and (gut-related) diseases. Secondly, the 92 relevance and the applications of the currently-available anaerobe-epithelial co-culture 93 systems will be discussed. 94 95 96
The role of the gut microbiota 97
The human gut contains a wide variety of different microorganisms. Bacteria, viruses, 98 archaea, yeast and fungi colonize the bowel. 2 The bacterial part of the microbiota is the 99 most studied and best described of these different microorganisms. 3 The trillions of 100 bacteria that inhabit the gut of each individual belong to hundreds of different species. 4,5 101
The composition of the gut microbiota is highly dynamic and different for each human 102 individual and changes during the course of life. 6 The bacterial phyla Bacteroidetes and 103
Firmicutes are the most prevalent in adults and together they form the majority of the gut 104 bacteria. 4, 5 The microbiota in the gut has many crucial functions in human health and 105 affects the host via different host-microbiota interaction pathways. 7-9 For example, 106
intestinal microbiota enable fermentation of complex non-digestible carbohydrates and 107 produce short-chain fatty acids (SCFAs), such as acetate, propionate and butyrate. 10,11 108 Several anaerobic bacteria that dominate a healthy gut, such as Faecalibacterium M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
prausnitzii and Roseburia species, are major butyrate producers. 12, 13 Butyrate is known 110 to be an important energy source for colonocytes, and is suggested to enhance intestinal 111 barrier function. 14 Moreover, butyrate is known to possess anti-inflammatory properties 112 and even possible anti-cancer effects. [10] [11] [12] 15 In addition, the 'healthy gut microbiome' 113 plays an important role in the development of a balanced immune-system. A certain level 114 of immunological tolerance exists for the intraluminal bacteria in a healthy gut. Extensive 115 profiling of the human gut microbiome has shown that several common diseases are 116 associated with "dysbiosis" of the gut microbiota. The term dysbiosis is often used to 117 describe a disturbed balance between 'beneficial' bacteria with anti-inflammatory 118
properties and pathobionts with pro-inflammatory properties. Moreover, many diseases 119 are associated with a decreased diversity of the gut microbiota. 16-18 120 121 For the majority of diseases it remains unclear to which extent the dysbiosis is the cause 122 or the consequence of the disease and/or treatment. 19 This issue is further complicated by 123 the fact that many studies investigate the bacterial composition of the fecal material, 124 which may significantly differ from the bacterial composition attached to the mucosa 125 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 6 triggered by the commensal microbiota in a genetically predisposed host. [23] [24] [25] [26] [27] Changes in 133 the gut microbiome seem more apparent in CD than in UC. 28,29 Also, CD patients show a 134 less diverse microbiota profile than healthy individuals. 30, 31 Typically, a decrease in 135 abundance of Bacteroides and Firmicutes is detected, together with an increase in 136 proteobacteria and fusobacteria. 22 A consistent observation is a decreased abundance of 137 butyrate-producing F. prausnitzii and an increased number of Adherent-invasive 138
Escherichia coli (AIEC) in CD patients. 22, [32] [33] [34] [35] [36] In addition, an increase of the mucin-139 degrading bacterium Ruminococcus gnavus has been described. 21 CD patients with 140 higher numbers of pathobionts, such as E. coli, and lower proportions of F. prausnitzii 141 have an increased risk of endoscopic recurrent disease after ileal/ileocecal resection. 37,38 142 Furthermore, CD patients with the lowest abundance of F. prausnitzii often have a less 143 favorable disease course, with worse disease scores and elevated inflammatory markers. 144 39 In line with these observations, the abundance of F. prausnitzii may even function as a 145 biomarker for predicting disease course in CD patients. 40,41 146 147 Another example of a disease in which an aberrant microbiota composition is observed is 148 celiac disease. In the duodenum of these patients typically an increase in Bacteroidetes is 149 detected. [42] [43] [44] [45] Also, an association between the gut microbiome and the development and 150 the progression of intestinal cancer has been described. 46 Moreover, different types of medication have adverse effects on the microbiota 173 composition. For example, treatment of bacterial infections with antibiotic drugs is 174 common in modern medicine. However, these drugs should be prescribed in a 175 conservative way, because of the profound effect of these drugs on the microbiota 176 composition. [66] [67] [68] Similarly, chemotherapeutic agents may have an even more detrimental 177 effect on the microbiota, with dramatic reductions in the number of anaerobic bacteria.
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A C C E P T E D ACCEPTED MANUSCRIPT 8 69,70 Also, a recent study, combining the data of three large Dutch cohorts, shows that 179 proton pump inhibitors (PPI's) negatively modify the microbiota and predispose to 180 Clostridium difficile infection. 71 'Improving' the composition of the gut microbiota is 181 therefore a promising target for the treatment of many diseases. For C. difficile infection, 182 fecal microbiota transplantation (FMT) has already been shown to be an effective and 183 highly successful treatment. 72, 73 However, FMT has shown to be less promising for IBD 184 patients. 74 Moreover, FMT has several risks, such as potential transmission of viruses. 
Models for gut bacteria 281
Examples of systems that are used to study the human gut microbiota in isolation are the 282 TNO dynamic in vitro model of the human large intestine (TIM-2), the Simulator of the 283 Human Intestinal Microbial Ecosystem (SHIME), the "Three stage continuous culture 284 system", the Lacroix model and the fecal minibioreactor arrays (MBRAs). 95-98 The TIM-285 2 is designed to simulate the conditions found in the proximal colon. 99 Accumulation of 286 metabolites in the lumen is prevented by constant and active removal of these metabolites 287 by means of a dialysis system. In addition, peristalsis, temperature and pH are controlled 288 in this system to mimic the in vivo human situation. The TIM-2 system allows for the 289 analysis of fermentation patterns and effects of prebiotic and probiotic supplement intake 290 on microbial composition. 100-105 The SHIME contains five connected vessels that are 291 designed to closely mimic the bacterial compartment of the gastrointestinal tract of an 292 adult human. 106 Each reactor simulates a different part of the GI-tract: stomach, small 293 intestine, ascending colon, transverse colon and descending colon. In this model, the 294
intraluminal content' is continuously stirred and pH-controlled. In addition, pancreatic 295 enzymes and bile are added to more closely resemble the in vivo situation. In this model 296 the fermentation patterns of four polysaccharides were shown to be similar to the 297 fermentation pattern that occurs in vivo. 107 The SHIME is relevant for intervention 298 studies, such as supplementation studies of different probiotic strains or prebiotics. 108-110 299
The "Three stage continuous culture system" comprises three culture vessels, simulating 300 the ascending, transverse and descending colon. This system simulates the nutritional and 301 environmental conditions in the human large intestine. Oxygen-free conditions, pH 302 control and transit time closely resemble the in vivo situation. 95, 111, 112 The Lacroix model 303 is also a three stage continuous culture system, which uses immobilized fecal microbiota 304 and is used to simulate fermentation of the infant colon. 97, 113 Finally, the fecal 305 minibioreactor array (MBRA) is another in vitro system used to cultivate and investigate 306 fecal microbiota communities. In these bioreactors, consisting of six single vessel 307 chambers in an anaerobic chamber, the diluted feces of multiple human donors is used. In 308 one study this system is used to test competition between different ribotypes of C. An in vitro gut host-microbe co-culture system would have many advantages for 321 unraveling the direct role of gut bacteria in intestinal health, provided that it is robust and 322 truly simulates the gut ecosystem. A schematic figure of the host-microbe interaction at 323 the aerobe-anaerobe interphase is shown in Figure 1A . Below, we give a concise 324 overview of recently developed systems that enable the co-culture of (anaerobic) gut 325 bacteria and (oxygen-requiring) epithelial cells (also see Table 1 for a comparative 326 overview). 
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III) The 3 rd system that aims to simulate host-microbe interactions occurring at the oxic-408 anoxic interphase of the (human) gut is the 'Human oxygen Bacteria anaerobic' 409 (HoxBan) co-culturing system (see Figure 1D) . In contrast to the previously described 
IV) A 4 th system that is relevant for host-microbe interaction studies is the human gut-453
on-a-chip (see Figure 1E ). However, in contrast to the previously described systems, its 454 use for co-culturing human cells with strict anaerobic gut bacteria has not been performed 455 yet and it may be technically very challenging to maintain both aerobic and (strict) 456 anaerobic conditions in this system. Still, very interesting results were obtained when co-457 anaerobe Lactobacillus rhamnosus GG (LGG), which was also studied in the gut-on-a 511 chip (see above). Both the oxygen-requiring Caco-2 cells and the facultative anaerobe 512
LGG remain viable during co-culture. Integrated oxygen sensors in this device allow the 513 real time monitoring of dissolved oxygen concentrations. Clearly different oxygen levels 514 were detected between the "perfusion microchamber" and the "microbial microchamber", 515 though the latter was not completely devoid of oxygen. Still, the authors show that this 516 device can also be used to study the effect of obligate anaerobic bacteria in co-culture 517 with Caco-2 cells. The obligate anaerobic strain Bacteroides caccae (of the phylum 518 
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Concluding remarks 540
Dysbiosis of the gut microbiota is associated with many common diseases, however 541 limited tools are available to determine what is the cause or consequence of this 542 phenomenon. In vitro models for host-microbe interactions occurring in the (largely 543 anaerobic) gut are instrumental to analyze the molecular and cellular mechanisms 544 involved. Several (anaerobic) bacteria-gut epithelial co-culture systems models have 545 recently been developed. A comparative overview of the characteristics and applications 546 of these systems is given in Table 1 . Each of these systems has its own pros and cons, 547 and the specific research question will largely determine which system is most suitable to 548 use. Key factors to consider are 1) whether a strict anaerobic compartment for gut 549 bacteria is required; 2) whether single or complex mixtures of bacteria need to be 550 analyzed; 3) whether direct contact with bacteria and gut epithelial cells is important, 4) 551 whether analysis of the barrier function (such as TEER) is needed; 5) whether effects on 552 both gut epithelia, as well as bacterial metabolism will be analyzed; and maybe at least as 553 important 6) whether the equipment and infrastructure is available to perform such 554 experiments. A major "weakness" of all systems so far is that they all rely on the use of 555 Caco-2 cells as representative of the human gut epithelium. Still, Caco-2 cells originate 556 from heterogeneous human epithelial colorectal adenocarcinoma and may therefore 557 behave quite differently as compared to true human gut epithelium. Recent advancements 558 in generating primary human epithelium from intestinal stem cells hold great promise for 559 "upgrading" these host-microbe co-culturing systems with location-specific and/or 560 
